0001140361-13-017306.txt : 20130424 0001140361-13-017306.hdr.sgml : 20130424 20130424153020 ACCESSION NUMBER: 0001140361-13-017306 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130424 DATE AS OF CHANGE: 20130424 EFFECTIVENESS DATE: 20130424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurovance, Inc. CENTRAL INDEX KEY: 0001544176 IRS NUMBER: 454090332 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-185561 FILM NUMBER: 13779228 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-758-0300 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0706 D/A LIVE 0001544176 Neurovance, Inc. 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA MASSACHUSETTS 02141 617-758-0300 DELAWARE None None Corporation true 2011 Anthony A. McKinney 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director Franklin P. Bymaster 8545 N. Country Road 650 East Brownsburg IN INDIANA 46112 Executive Officer Campbell Murray Novartis BioVentures Ltd. Five Cambridge Center, Suite 603 Cambridge MA MASSACHUSETTS 02142 Director Frank Gentile H&Q Healthcare Investors 2 Liberty Square, 9th Floor Boston MA MASSACHUSETTS 02109 Director Joshua Funder GBS Venture Partners Limited Level 5, 71 Collins Street Melbourne VIC C3 AUSTRALIA 3000 Director Paul Weiss Venture Investors Early Stage Fund IV 505 South Rosa Road, Suite 201 Madison WI WISCONSIN 53719 Director Timothy J. Barberich 48 Elm Street Concord MA MASSACHUSETTS 01742 Director Pierre Tran 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Thomas A. Shea 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Other Technology No Revenues 06 true 0001140361-12-043764 2012-10-11 true true false 32691 7000000 6000000 1000000 The offering will close in 3 separate tranches if certain milestones are met. The first tranche of $3,000,000 closed 10/11/12, and the second tranche of $3,000,000 closed 4/23/13. false 7 0 0 0 true false Neurovance, Inc. Douglas A. Branch Douglas A. Branch Secretary 2013-04-24